Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study

J Am Acad Dermatol. 2024 Dec;91(6):1217-1219. doi: 10.1016/j.jaad.2024.07.1491. Epub 2024 Aug 12.
No abstract available

Keywords: anifrolumab; dermatomyositis; refractory; type I interferon.